Please assess the completion status of the following clinical trial:

Trial Title: Treatment of Uterine Fibroids With Asoprisnil(J867)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE3
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Premenopausal women~* History of regular menstrual cycles (21-42 days)~* Diagnosis of uterine fibroid(s)~* Abnormal vaginal bleeding associated with uterine fibroids~* Otherwise in good health~* Agrees to undergo surgery (hysterectomy) or any other invasive procedure if the study medication fails~* Negative pregnancy test~* Agrees to Double-barrier method of contraception~* Pap smear with no evidence of malignancy or pre-malignant changes~* Endometrial biopsy with no significant histological disorder~Exclusion Criteria:~* Any abnormal lab or procedure result the study-doctor considers important~* Severe reaction(s) to or are currently using any hormone therapy~* History of osteoporosis or other bone disease~* Previous myomectomy with 1 year and/or previous uterine artery embolization within 6 months~* History of Polycystic Ovary Syndrome or prolactinoma~* MRI shows significant gynecologic disorder~* Uterine size \> 25 weeks gestation~* Hemoglobin \< 8 g/dL at Day -1

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): None
- 2 (Type: EXPERIMENTAL): None
- 3 (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).